123 related articles for article (PubMed ID: 2586490)
1. Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
Moran RG; Colman PD; Jones TR
Mol Pharmacol; 1989 Nov; 36(5):736-43. PubMed ID: 2586490
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for the activity of antifolates as substrates for mammalian folylpolyglutamate synthetase.
Moran RG; Colman PD; Rosowsky A
NCI Monogr; 1987; (5):133-8. PubMed ID: 2448651
[TBL] [Abstract][Full Text] [Related]
3. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
Sanghani PC; Jackman A; Evans VR; Thornton T; Hughes L; Calvert AH; Moran RG
Mol Pharmacol; 1994 Feb; 45(2):341-51. PubMed ID: 8114682
[TBL] [Abstract][Full Text] [Related]
4. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human liver folylpolyglutamate synthetase by non-gamma-glutamylatable antifolate analogs.
Clarke L; Rosowsky A; Waxman DJ
Mol Pharmacol; 1987 Jan; 31(1):122-7. PubMed ID: 3807889
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
Habeck LL; Mendelsohn LG; Shih C; Taylor EC; Colman PD; Gossett LS; Leitner TA; Schultz RM; Andis SL; Moran RG
Mol Pharmacol; 1995 Aug; 48(2):326-33. PubMed ID: 7651366
[TBL] [Abstract][Full Text] [Related]
8. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
Moran RG; Colman PD; Rosowsky A; Forsch RA; Chan KK
Mol Pharmacol; 1985 Jan; 27(1):156-66. PubMed ID: 3838105
[TBL] [Abstract][Full Text] [Related]
9. Folate analogues as substrates of mammalian folylpolyglutamate synthetase.
Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG
Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989
[TBL] [Abstract][Full Text] [Related]
10. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
Johnson TB; Nair MG; Galivan J
Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
[TBL] [Abstract][Full Text] [Related]
11. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
McGuire JJ; Piper JR; Coward JK; Galivan J
NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
Mao Z; Pan J; Kalman TI
J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
[TBL] [Abstract][Full Text] [Related]
13. Structural specificity of inhibition of human folylpolyglutamate synthetase by ornithine-containing folate analogs.
McGuire JJ; Bolanowska WE; Piper JR
Biochem Pharmacol; 1988 Oct; 37(20):3931-9. PubMed ID: 3190739
[TBL] [Abstract][Full Text] [Related]
14. 5-deazafolate analogues with a rotationally restricted glutamate or ornithine side chain: synthesis and binding interaction with folylpolyglutamate synthetase.
Rosowsky A; Forsch RA; Null A; Moran RG
J Med Chem; 1999 Sep; 42(18):3510-9. PubMed ID: 10479284
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human folylpolyglutamate synthetase by suramin.
McGuire JJ; Haile WH
Arch Biochem Biophys; 1996 Nov; 335(1):139-44. PubMed ID: 8914844
[TBL] [Abstract][Full Text] [Related]
16. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
[TBL] [Abstract][Full Text] [Related]
17. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
Rumberger BG; Barrueco JR; Sirotnak FM
Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
[TBL] [Abstract][Full Text] [Related]
18. In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase.
Hanlon MH; Ferone R
Cancer Res; 1996 Jul; 56(14):3301-6. PubMed ID: 8764125
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
Tsukamoto T; Haile WH; McGuire JJ; Coward JK
Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
[TBL] [Abstract][Full Text] [Related]
20. Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonists.
Clarke L; Waxman DJ
Arch Biochem Biophys; 1987 Aug; 256(2):585-96. PubMed ID: 3619447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
